Oral immunosuppressive medication for growing pigs in transplantation studies

Laboratory Animals

Volumn 46, Issue 2, 2012, Pages 148-151

  Jensen Waern, M ^a   Kruse, R ^b   Lundgren, T ^c  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Maintenance dosage; Mycophenolic acid; Swine; Tacrolimus; Transplantation

Indexed keywords

BILIRUBIN; ELECTROLYTE; GLUCOSE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOBARBITAL; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HEALTH STATUS; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; INTESTINE FLORA; LEUKOCYTE COUNT; MAINTENANCE THERAPY; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE PERIOD; SWINE; WEIGHT GAIN; ANIMAL; ANIMAL DISEASE; BLOOD; CLINICAL PROTOCOL; DISEASE MODEL; DRUG ADMINISTRATION; GERMFREE ANIMAL; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TOXICITY TESTING;

ADMINISTRATION, ORAL; ANIMALS; CLINICAL PROTOCOLS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; TACROLIMUS; TOXICITY TESTS;

EID: 84864865498     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2012.011152     Document Type: Article

References (23)

1. Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6: 1111-31
2. 2009 OPTN/SRTR Annual Report: Transplant Data 1999-2008. See http://optn.transplant.hrsa.gov/ar2009/109a_dh.htm
3. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-33
4. Ekberg H, Tedesco-Silva H, Demirbas A, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-75
5. Bumbea V, Kamar N, Ribes D, et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 2005; 20: 2517-23
6. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506-14
7. Benhamou PY, Milliat-Guittard L, Wojtusciszyn A, et al. Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials. Diabet Med 2009; 26: 617-21
8. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-9
9. Toso C, Baertschiger R, Morel P, et al. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. Am J Transplant 2006; 6: 1049-58
10. Lehmann R, Weber M, Berthold P, et al. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up. Am J Transplant 2004; 4: 1117-23
11. Larsen MO, Rolin B. Use of the Göttingen minipig as a model of type 1 diabetes research, with special focus on type 1 diabetes research. ILAR J 2004; 45: 303-13
12. Gabel H, Bitter-Suermann H, Henriksson C, Save-Soderbergh J, Lundholm K, Brynger H. Streptozotocin diabetes in juvenile pigs. Evaluation of an experimental model. Horm Metab Res 1985; 17: 275-80
13. Jensen-Waern M, Andersson M, Kruse R, et al. Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism. Lab Anim 2009; 43: 249-54
14. Eich T, Eriksson O, Sundin A, et al. Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 2007; 84: 893-8
15. Korsgren O, Lundgren T, Felldin M, et al. Optimising islet engraftment is critical for successful clinical islet transplantation. Diabetologia 2008; 51: 227-32
16. Regazzi MB, Alessiani M, Reggiani P, et al. Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplant Proc 1997; 29: 1857-60
17. van Gelder T, Silva HT, de Fijter JW, et al. Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation 2008; 86: 1043-51
18. Wallgren P, Vallgårda J. SPF pigs - presentation, definition and specification of regulations. Swed Vet J 1993; 45: 733-5
19. Rodrigues H, Kunavongkrit A. Chronical venous catheterization for frequent blood sampling in unrestrained pigs. Acta Vet Scand 1983; 24: 318-20
20. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80: S254-64
21. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-8
22. Hafiz MM, Faradji RN, Froud T, et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 2005; 80: 1718-28
23. Collaborative Islet Transplant Registry - Annual Report. Rockville, MD, 2007